Obesity White Papers & Case Studies
-
ePRO And Castor Connect
3/19/2024
Gather data directly from the patient—the true source. Empower your team to streamline data collection, making it faster and easier for everyone involved.
-
Digital Endpoint Resource Guide: Rheumatology
3/19/2024
Explore how wearables and sensor-based technologies provide continuous, remote patient-centered outcomes, reducing trial participation burdens, increasing success probabilities, and enhancing condition management.
-
psiXchange: Intelligent, Automated Safety Document Distribution Software
3/15/2024
Discover how psiXchange streamlines the distribution, tracking, and acknowledgment of key safety documents, saving time, resources, and costs for global drug manufacturers and research organizations.
-
Achieving Statistical Significance With Limited Patient Populations
3/15/2024
Explore highlights from a timely panel debate on emerging approaches to clinical research and data collection for advanced, novel and personalized therapies, especially linked to rare diseases.
-
Digital Endpoint Resource Guide: Neuromuscular Disorders
3/15/2024
Find out how sensor-based digital health technologies (DHTs) offer direct, objective daily life assessments, accelerating NMD drug development.
-
Rare Disease Prioritization Model And Landscape Analysis
3/15/2024
Uncover how a global pharmaceutical company seeking to identify promising indications among rare diseases to develop preclinical candidate molecules received an in-depth disease analysis to guide its strategic decision-making.
-
Lab Alerts: Target Relevant Patients For Clinical Trials
3/15/2024
Get near real-time notifications when a potential trial candidate presents in the clinic, which will help enable recruitment before the window of opportunity closes.
-
Bringing In Vitro Diagnostics To Market With Real-World Evidence
3/14/2024
Explore the potential of real-world evidence in enhancing the regulatory decision-making process to facilitate the market entry of IVDs.
-
Study Start-Up Challenges: Hard Realities, Effective Strategies
3/13/2024
Launching a study is complex, and the time between protocol approval and the first patient visit has increased dramatically. How can companies reverse this trend and accelerate study start-ups?
-
eConsent Readiness In 24 Countries
3/12/2024
Discover how regulatory bodies worldwide, including the U.S. Food and Drug Administration and the European Medicines Agency, are now championing the shift towards eConsent adoption.